Risk factors for non-adherence to medication in inflammatory bowel disease patients

R. D'Incà, P. Bertomoro, K. Mazzocco, M. G. Vettorato, R. Rumiati, G. C. Sturniolo

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Background: Inflammatory bowel diseases are chronic conditions requiring medication throughout life to treat the disease and control the risk of relapse and colorectal cancer. Adherence to prescribed drugs is therefore crucial to their management. Aim: To identify determinants and potential risk factors of non-adherence in inflammatory bowel disease patients. Methods: An anonymous 24-item questionnaire (available online as Supplementary material) was administered to 485 out-patients attending a tertiary referral centre. Results: Sixty-one per cent of the patients reportedly adhered to their treatment. No differences emerged between inflammatory bowel disease and socio-demographic characteristics other than age, non-adherence being significantly associated with cases under 40 years (43% vs. 34%, P = 0.041). The most common reasons for non-adherence vs. adherence were forgetfulness (61% vs. 44%, P = 0.000), disease remission (25% vs. 10%, P = 0.000), recent diagnosis (24% vs. 15%, P = 0.000) and full-time employment (55% vs. 26%, P = 0.000). Oral therapy was associated with a significantly better adherence than rectal therapy (60% vs. 32%, P = 0.001). Communication affects patient adherence: a significant interaction was found for adherence and patients

Original languageEnglish
Pages (from-to)166-172
Number of pages7
JournalAlimentary Pharmacology and Therapeutics
Volume27
Issue number2
DOIs
Publication statusPublished - Jan 2008

Fingerprint

Medication Adherence
Inflammatory Bowel Diseases
Patient Compliance
Tertiary Care Centers
Colorectal Neoplasms
Outpatients
Therapeutics
Communication
Demography
Recurrence
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Risk factors for non-adherence to medication in inflammatory bowel disease patients. / D'Incà, R.; Bertomoro, P.; Mazzocco, K.; Vettorato, M. G.; Rumiati, R.; Sturniolo, G. C.

In: Alimentary Pharmacology and Therapeutics, Vol. 27, No. 2, 01.2008, p. 166-172.

Research output: Contribution to journalArticle

D'Incà, R. ; Bertomoro, P. ; Mazzocco, K. ; Vettorato, M. G. ; Rumiati, R. ; Sturniolo, G. C. / Risk factors for non-adherence to medication in inflammatory bowel disease patients. In: Alimentary Pharmacology and Therapeutics. 2008 ; Vol. 27, No. 2. pp. 166-172.
@article{d37bd55ffed841edbc1196e663da50a4,
title = "Risk factors for non-adherence to medication in inflammatory bowel disease patients",
abstract = "Background: Inflammatory bowel diseases are chronic conditions requiring medication throughout life to treat the disease and control the risk of relapse and colorectal cancer. Adherence to prescribed drugs is therefore crucial to their management. Aim: To identify determinants and potential risk factors of non-adherence in inflammatory bowel disease patients. Methods: An anonymous 24-item questionnaire (available online as Supplementary material) was administered to 485 out-patients attending a tertiary referral centre. Results: Sixty-one per cent of the patients reportedly adhered to their treatment. No differences emerged between inflammatory bowel disease and socio-demographic characteristics other than age, non-adherence being significantly associated with cases under 40 years (43{\%} vs. 34{\%}, P = 0.041). The most common reasons for non-adherence vs. adherence were forgetfulness (61{\%} vs. 44{\%}, P = 0.000), disease remission (25{\%} vs. 10{\%}, P = 0.000), recent diagnosis (24{\%} vs. 15{\%}, P = 0.000) and full-time employment (55{\%} vs. 26{\%}, P = 0.000). Oral therapy was associated with a significantly better adherence than rectal therapy (60{\%} vs. 32{\%}, P = 0.001). Communication affects patient adherence: a significant interaction was found for adherence and patients",
author = "R. D'Inc{\`a} and P. Bertomoro and K. Mazzocco and Vettorato, {M. G.} and R. Rumiati and Sturniolo, {G. C.}",
year = "2008",
month = "1",
doi = "10.1111/j.1365-2036.2007.03555.x",
language = "English",
volume = "27",
pages = "166--172",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "2",

}

TY - JOUR

T1 - Risk factors for non-adherence to medication in inflammatory bowel disease patients

AU - D'Incà, R.

AU - Bertomoro, P.

AU - Mazzocco, K.

AU - Vettorato, M. G.

AU - Rumiati, R.

AU - Sturniolo, G. C.

PY - 2008/1

Y1 - 2008/1

N2 - Background: Inflammatory bowel diseases are chronic conditions requiring medication throughout life to treat the disease and control the risk of relapse and colorectal cancer. Adherence to prescribed drugs is therefore crucial to their management. Aim: To identify determinants and potential risk factors of non-adherence in inflammatory bowel disease patients. Methods: An anonymous 24-item questionnaire (available online as Supplementary material) was administered to 485 out-patients attending a tertiary referral centre. Results: Sixty-one per cent of the patients reportedly adhered to their treatment. No differences emerged between inflammatory bowel disease and socio-demographic characteristics other than age, non-adherence being significantly associated with cases under 40 years (43% vs. 34%, P = 0.041). The most common reasons for non-adherence vs. adherence were forgetfulness (61% vs. 44%, P = 0.000), disease remission (25% vs. 10%, P = 0.000), recent diagnosis (24% vs. 15%, P = 0.000) and full-time employment (55% vs. 26%, P = 0.000). Oral therapy was associated with a significantly better adherence than rectal therapy (60% vs. 32%, P = 0.001). Communication affects patient adherence: a significant interaction was found for adherence and patients

AB - Background: Inflammatory bowel diseases are chronic conditions requiring medication throughout life to treat the disease and control the risk of relapse and colorectal cancer. Adherence to prescribed drugs is therefore crucial to their management. Aim: To identify determinants and potential risk factors of non-adherence in inflammatory bowel disease patients. Methods: An anonymous 24-item questionnaire (available online as Supplementary material) was administered to 485 out-patients attending a tertiary referral centre. Results: Sixty-one per cent of the patients reportedly adhered to their treatment. No differences emerged between inflammatory bowel disease and socio-demographic characteristics other than age, non-adherence being significantly associated with cases under 40 years (43% vs. 34%, P = 0.041). The most common reasons for non-adherence vs. adherence were forgetfulness (61% vs. 44%, P = 0.000), disease remission (25% vs. 10%, P = 0.000), recent diagnosis (24% vs. 15%, P = 0.000) and full-time employment (55% vs. 26%, P = 0.000). Oral therapy was associated with a significantly better adherence than rectal therapy (60% vs. 32%, P = 0.001). Communication affects patient adherence: a significant interaction was found for adherence and patients

UR - http://www.scopus.com/inward/record.url?scp=37149053152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37149053152&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2036.2007.03555.x

DO - 10.1111/j.1365-2036.2007.03555.x

M3 - Article

VL - 27

SP - 166

EP - 172

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 2

ER -